We summarised SLAS2016 for you!

SLAS2016 saw the introduction of ameon, the new lifetime reader for robust high-throughput biochemical screening

We were proud to present the new lifetime screening solutions bameon_featured_imagerought to you by TTP Labtech’s ameon reader and Almac’s FLEXYTE lifetime reagents. This collaboration enables straightforward implementation of the fluorescence lifetime technology into even the most challenging HTS and profiling workflows. 

>> Watch the recorded tutorial!

>>View the poster!

miniaturised, low-cost single-cell transcriptome sequencing

InSLAS2016 tutorial Louise this tutorial, Dr. Louise Laurent, MD, PhD (UC San Diego) presents the use of mosquito positive displacement liquid handlers in preparing 2 µL Nextera XT libraries with as little as 20 pg of cDNA. Dr. Laurent also demonstrates how this automated high-throughput method saves time and money.

>> Watch the recorded tutorial!

>> Read the open source JALA publication!

>> View the poster

making 1536 direct dilution of compounds possible with mosquito HTS, a low-volume automated liquid handler

Jose Quiroz, Associate Director, Compound Management (Dart NeuroScience LLC)  talks about how TTP Labtech’s automated low volume liquid handler, mosquito HTS can create a semi-direct dilution series into 1536-well plates. This method has many benefits over the gold standard serial dilution method.

>> Read the SLAS2016 poster!

 

high-throughput mass spectometry using mosquito HTS

The new, fully automated MALDI PharmaPulse™ system is a high-throughput MS solution that has been developed to screen over 100,000 samples per day.

>> View the brochure! 

introducing the new sol-RTM beads for mirrorball

mirrorball and the new sol-RTM beads enable a multiplexed assay approach for screening and hit characterisation assays using both cell- and bead-based methods. We presented how the versatile nature, and advantages of multiplexing assays using mirrorball can improve the productivity of biologics discovery.

>> View the poster

eliminating the false negatives in ATP-luminescence cell health assays by the use of a phenotypic assay approach

ATP-luminescence measurements can significantly overestimate toxicity and underestimate potency, leading to false-negative viability/efficacy hits. Here we show the development and implementation of an alternative no-wash HCA assay, which eliminates common problems associated with ATP-luminescence measurements. We compare the drug-responses of several well-characterised anti-cancer drugs on HeLa cells, measured by both the HCA assay and a commercial ATP-luminescence detection system, and highlight key differences between the measurements.

>> View the poster

google3be5092f5d38b5a9